Nursing and Health Professions
Patient
100%
Pharmacy
50%
Drug Therapy
44%
Procedures
42%
Psoriasis
35%
Primary Medical Care
29%
Error
27%
Prevalence
22%
General Practice
20%
Analysis
19%
Hospital
17%
Incidence
17%
Time
17%
Clinical Practice
15%
Biological Product
15%
Prescription
14%
Confidence Interval
13%
Physician
13%
Community Pharmacist
12%
Data Base
12%
Indicator
12%
Infection
11%
Diagnosis
11%
Systematic Review
10%
Inpatient
9%
Child
9%
Adverse Drug Reaction
9%
Dose
9%
Non Insulin Dependent Diabetes Mellitus
9%
Cohort Analysis
9%
Diabetes Mellitus
8%
Adult
8%
Drug
7%
Mortality
7%
Dermatologist
7%
Medication Error
7%
Gender
7%
Electric Potential
7%
Adalimumab
7%
Hospital Admission
7%
Ustekinumab
6%
Monitoring
6%
Etanercept
6%
Health Care Personnel
6%
Combination Therapy
6%
Cardiovascular Disease
6%
Evaluation Study
6%
Biological Therapy
6%
Malignant Neoplasm
5%
Automutilation
5%
Medicine and Dentistry
Patient
71%
Psoriasis
36%
Incidence
22%
Drug Therapy
21%
Therapeutic Procedure
16%
Age
15%
Maturity Onset Diabetes of the Young
13%
Prevalence
13%
Association
13%
Diagnosis
13%
Automutilation
12%
Mortality
12%
Health
12%
Inpatient
11%
Primary Health Care
11%
Cohort Analysis
10%
Diabetes
10%
Male
9%
Analysis
9%
COVID-19
8%
Death
8%
Cardiovascular Disease
8%
Hazard Ratio
8%
Suicide
7%
Neurodevelopmental Disorder
7%
Malignant Neoplasm
7%
Infection
7%
Follow up
7%
Community Pharmacy
7%
Adverse Drug Reaction
6%
Depression
6%
Sex
6%
Biological Therapy
6%
Methotrexate
6%
Drug
6%
Chemotherapeutic Agent
6%
Systemic Therapy
5%
Cardiovascular System
5%
Diseases
5%
Mental Health
5%
Patient Safety
5%
Child
5%
Adult
5%
Person
5%
Pharmacology, Toxicology and Pharmaceutical Science
Community Pharmacy
25%
Psoriasis
24%
Drug
18%
Infection
17%
Prevalence
16%
Biological Product
16%
Antibiotics
14%
Adverse Drug Reaction
12%
Incidence
10%
Adverse Event
9%
Methotrexate
7%
Death
6%
Antibiotic Agent
6%
Adalimumab
6%
Cardiovascular Disease
6%
Ustekinumab
6%
Etanercept
5%
Randomized Controlled Trial
5%
Indicator
5%
Toxic Injury
5%
